161 related articles for article (PubMed ID: 27190374)
21. A Clinical Significance of Intermittent Infusion Hemodiafiltration Using Backfiltration of Ultrapure Dialysis Fluid Compared to Hemodialysis: A Multicenter Randomized Controlled Crossover Trial.
Mineshima M; Takahashi S; Tomo T; Kawanishi H; Kawaguchi H; Minakuchi J; Nakanishi T; Sato T; Nitta K; Tsuchiya K; Masakane I; Itami N
Blood Purif; 2019; 48(4):368-381. PubMed ID: 31311018
[TBL] [Abstract][Full Text] [Related]
22. Pneumatic Compression, But Not Exercise, Can Avoid Intradialytic Hypotension: A Randomized Trial.
Álvares VRC; Ramos CD; Pereira BJ; Pinto AL; Moysés RMA; Gualano B; Elias RM
Am J Nephrol; 2017; 45(5):409-416. PubMed ID: 28407637
[TBL] [Abstract][Full Text] [Related]
23. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
24. Interventional study to improve adherence to phosphate binder treatment in dialysis patients.
Hjemås BJ; Bøvre K; Mathiesen L; Lindstrøm JC; Bjerknes K
BMC Nephrol; 2019 May; 20(1):178. PubMed ID: 31101020
[TBL] [Abstract][Full Text] [Related]
25. Impact of convective flow on phosphorus removal in maintenance hemodialysis patients.
Lornoy W; De Meester J; Becaus I; Billiouw JM; Van Malderen PA; Van Pottelberge M
J Ren Nutr; 2006 Jan; 16(1):47-53. PubMed ID: 16414441
[TBL] [Abstract][Full Text] [Related]
26. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.
Weinreich T; Ritz E; Passlick-Deetjen J
Perit Dial Int; 1996; 16(3):260-8. PubMed ID: 8761540
[TBL] [Abstract][Full Text] [Related]
27. A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients.
Bleyer AJ; Burke SK; Dillon M; Garrett B; Kant KS; Lynch D; Rahman SN; Schoenfeld P; Teitelbaum I; Zeig S; Slatopolsky E
Am J Kidney Dis; 1999 Apr; 33(4):694-701. PubMed ID: 10196011
[TBL] [Abstract][Full Text] [Related]
28. Phosphate Kinetics During Weekly Cycle of Hemodialysis Sessions: Application of Mathematical Modeling.
Debowska M; Poleszczuk J; Wojcik-Zaluska A; Ksiazek A; Zaluska W
Artif Organs; 2015 Dec; 39(12):1005-14. PubMed ID: 25994493
[TBL] [Abstract][Full Text] [Related]
29. Intradialytic kinetics of middle molecules during hemodialysis and hemodiafiltration.
Leypoldt JK; Storr M; Agar BU; Boschetti-de-Fierro A; Bernardo AA; Kirsch AH; Rosenkranz AR; Krieter DH; Krause B
Nephrol Dial Transplant; 2019 May; 34(5):870-877. PubMed ID: 30307514
[TBL] [Abstract][Full Text] [Related]
30. Effect of increasing dialysate flow rate on diffusive mass transfer of urea, phosphate and beta2-microglobulin during clinical haemodialysis.
Bhimani JP; Ouseph R; Ward RA
Nephrol Dial Transplant; 2010 Dec; 25(12):3990-5. PubMed ID: 20543211
[TBL] [Abstract][Full Text] [Related]
31. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
32. Phosphorus Clearance Using Two Hemodialyzers Placed in Parallel.
Rosner MH; Helmandollar A; Evans R; Abdel-Rahman E
Hemodial Int; 2002 Jan; 6(1):15-19. PubMed ID: 28455934
[TBL] [Abstract][Full Text] [Related]
33. Relationship between effective ionic dialysance and in vivo urea clearance during hemodialysis.
Lindsay RM; Bene B; Goux N; Heidenheim AP; Landgren C; Sternby J
Am J Kidney Dis; 2001 Sep; 38(3):565-74. PubMed ID: 11532690
[TBL] [Abstract][Full Text] [Related]
34. Impact of blood and dialysate flow and surface on performance of new polysulfone hemodialysis dialyzers.
Mandolfo S; Malberti F; Imbasciati E; Cogliati P; Gauly A
Int J Artif Organs; 2003 Feb; 26(2):113-20. PubMed ID: 12653344
[TBL] [Abstract][Full Text] [Related]
35. Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients Receiving Maintenance Hemodialysis.
Edmonston DL; Isakova T; Dember LM; Brunelli S; Young A; Brosch R; Beddhu S; Chakraborty H; Wolf M
Am J Kidney Dis; 2021 Jun; 77(6):920-930.e1. PubMed ID: 33279558
[TBL] [Abstract][Full Text] [Related]
36. Phosphate Removal During Conventional Hemodialysis: a Decades-Old Misconception.
Elias RM; Alvares VRC; Moysés RMA
Kidney Blood Press Res; 2018; 43(1):110-114. PubMed ID: 29414834
[TBL] [Abstract][Full Text] [Related]
37. National Kidney Foundation report on dialyzer reuse. Task Force on Reuse of Dialyzers, Council on Dialysis, National Kidney Foundation.
Am J Kidney Dis; 1997 Dec; 30(6):859-71. PubMed ID: 9398135
[TBL] [Abstract][Full Text] [Related]
38. Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance.
Mudge DW; Rogers R; Hollett P; Law B; Reiger K; Petrie JJ; Price L; Johnson DW; Campbell SB; Isbel NM; Sullivan M; Hawley CM
Nephrol Dial Transplant; 2005 Oct; 20(10):2178-85. PubMed ID: 16030045
[TBL] [Abstract][Full Text] [Related]
39. Automated individualization of dialysate sodium concentration reduces intradialytic plasma sodium changes in hemodialysis.
Ságová M; Wojke R; Maierhofer A; Gross M; Canaud B; Gauly A
Artif Organs; 2019 Oct; 43(10):1002-1013. PubMed ID: 30939213
[TBL] [Abstract][Full Text] [Related]
40. Multidisciplinary education approach to optimize phosphate control among hemodialysis patients.
Chan MW; Cheah HM; Mohd Padzil MB
Int J Clin Pharm; 2019 Oct; 41(5):1282-1289. PubMed ID: 31302884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
